Home > Journals > Acta Phlebologica > Past Issues > Acta Phlebologica 2020 December;21(3) > Acta Phlebologica 2020 December;21(3):42-7

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Acta Phlebologica 2020 December;21(3):42-7

DOI: 10.23736/S1593-232X.20.00472-5

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Study of quality of life in patients with varicose vein after radiofrequency ablation and ultrasound guided foam sclerotherapy

Satyendra K. TIWARY 1 , Sartaz ALAM 1, Pankaj SUREKA 2, Puneet KUMAR 1, Ajay K. KHANNA 1

1 Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India; 2 Department of Psychiatry, Institute of Medical Sciences, Varanasi, India



BACKGROUND: Chronic venous insufficiency manifests most commonly as varicose veins affecting quality of life in significant way due to morbidity, recurrence and economic burden. This study was done in varicose veins to assess the quality of Life in varicose vein patients after treatment with radiofrequency ablation (RFA) and ultrasound guided foam sclerotherapy (UGFS) in great saphenous vein (GSV) in selected patients.
METHODS: In our study, in 30 patients UGFS and in another 30 patients RFA therapy in GSV was done. After these procedures, health related quality of life (HRQOL) was assessed with help of SF-36 and Venous Clinical Severity Score (VCSS). At pretreatment SF-36 and VCCS scoring was assessed and then reassessed all the parameter at 1 month, 6 months and 1 year. Higher the score, good is the quality of life.
RESULTS: The pretreatment scoring in both the group was comparable but not significant. But in subsequent follow-up HRQOL is better in RFA group patients than the USGFS group and statistically significant (P<0.05). The eight domain of SF-36 denoting different dimension of HRQOL were insignificant and comparable (P>0.05) in pretreatment level, but attained higher scoring in follow-up more than the UGFS group and significant (P<0.05).
CONCLUSIONS: Higher scores of SF36 and VCSS found in RFA group patients along with low recurrence of varicose veins, less complications related to RFA denotes that the HRQOL is much better in patients undergoing RFA as compared to UGFS.


KEY WORDS: Varicose veins; Quality of life; Radiofrequency ablation; Sclerotherapy

top of page